| scholarly article | Q13442814 |
| P2093 | author name string | Jian Wang | |
| Shi-Feng Kan | |||
| Guan-Xing Sun | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Dietary factors and epigenetic regulation for prostate cancer prevention | Q26991774 | ||
| Major clinical research advances in gynecologic cancer in 2014 | Q26992183 | ||
| HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients | Q33305210 | ||
| Seromic profiling of ovarian and pancreatic cancer | Q33739967 | ||
| Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions | Q33896639 | ||
| Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer | Q34152848 | ||
| Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells | Q34516308 | ||
| Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse | Q34596182 | ||
| Multi-targeted prevention of cancer by sulforaphane | Q34781826 | ||
| Expression of the MT1 melatonin receptor in ovarian cancer cells | Q34835245 | ||
| Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention | Q35007040 | ||
| Sulforaphane inhibits invasion via activating ERK1/2 signaling in human glioblastoma U87MG and U373MG cells | Q35109117 | ||
| Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathway | Q35210298 | ||
| Immunotherapeutic approaches to ovarian cancer treatment | Q35213535 | ||
| Fertility preservation in female cancer patients: An overview | Q35237851 | ||
| Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. | Q35386131 | ||
| Rethinking ovarian cancer: recommendations for improving outcomes | Q36050883 | ||
| Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells | Q36512713 | ||
| Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. | Q36625295 | ||
| Premature menopause | Q36789707 | ||
| DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas. | Q36889676 | ||
| Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter | Q36966230 | ||
| Olaparib: a review of its use as maintenance therapy in patients with ovarian cancer | Q38433579 | ||
| Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis | Q39036074 | ||
| Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells. | Q39051145 | ||
| Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation | Q39923869 | ||
| Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells | Q39977305 | ||
| Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity | Q40034367 | ||
| A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells | Q40171730 | ||
| Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells | Q40375288 | ||
| Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line | Q40382268 | ||
| Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. | Q40430279 | ||
| Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling | Q46336155 | ||
| Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement | Q54092157 | ||
| Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer | Q57904929 | ||
| Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells | Q85213795 | ||
| Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane | Q87125582 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 2447-2458 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer | |
| P478 | volume | 42 |
| Q89510873 | Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer |
| Q95270493 | Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects |
| Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
| Q92731356 | The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application |
Search more.